drugset / Trial / NCT02818543
Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study to assess the pharmacokinetic profile in patients with active ulcerative colitis and compare it to the experience in healthy volunteers.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LYC-30937 | Unknown | 25 mg | Oral |
| Subject | LYC-30937 | Unknown | 100 mg | Oral |